TXNDC5 is a novel therapeutic target of atrial fibrosis and fibrillationP. C. Wu, B. C. Lin,Y. H. Yeh,W. J. Chen,K. C. YangEUROPEAN HEART JOURNAL(2019)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要